nasal delivery
Nasal delivery puts a drug onto the moist lining inside the nose, either to act locally (like a decongestant or allergy spray) or to be absorbed into the bloodstream. The nose is a surprisingly good absorption surface: it is thin, richly supplied with blood vessels, and reached without a needle, so for some drugs a sniff can rival an injection for speed.
The nasal mucosa is well perfused and relatively permeable, and because the absorbed drug enters the systemic circulation directly it bypasses first-pass liver metabolism. Most products are aqueous sprays delivered by a metered pump that produces droplets large enough (typically tens of micrometres) to deposit in the nose rather than be inhaled into the lungs. A special bonus is the olfactory region high in the nose, which offers a possible direct nose-to-brain pathway for some central-nervous-system drugs, though how much this contributes in humans is debated.
The main limitation is the nose's own defence: mucociliary clearance constantly sweeps the lining toward the throat, giving a drug only minutes to be absorbed before it is swallowed. Volume is also limited (only about 100–150 µL per nostril stays put; more just drips out), and irritation, a runny or blocked nose, and variable absorption can all reduce reliability. Mucoadhesive formulations and permeation enhancers are used to extend contact time and uptake.
Naloxone nasal spray reverses opioid overdose in minutes by being absorbed rapidly through the nasal mucosa, letting a bystander treat an unconscious person without any injection.
Rapid mucosal absorption can make a nasal spray a needle-free alternative to injection.